Association of the Chimpanzee Coryza Agent with Acute Respiratory Disease in Children

IN 1956 Morris, Blount and Savage¹ described the recovery of a cytopathogenic agent that produced acute respiratory illness in chimpanzees and possibly in human beings. They termed this the chimpanzee coryza agent. In 1957 Chanock and his co-workers^{2 , 3} reported two isolations of a similar agent from infants with respiratory illness. They also found serologic evidence of infection of a number of additional children from whom it had not been possible to isolate the virus. On the basis of serologic responses, this infection was shown to occur in a significantly greater portion of outpatients with respiratory infections than in those without . . .